Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Gross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesWages, Salaries and Other
Ratios

Amphastar Pharmaceuticals (AMPH) Receivables - Net (2016 - 2026)

Amphastar Pharmaceuticals has reported Receivables - Net over the past 13 years, most recently at $143.6 million for Q4 2025.

  • For Q4 2025, Receivables - Net rose 5.33% year-over-year to $143.6 million; the TTM value through Dec 2025 reached $143.6 million, up 5.33%, while the annual FY2025 figure was $143.6 million, 5.33% up from the prior year.
  • Receivables - Net for Q4 2025 was $143.6 million at Amphastar Pharmaceuticals, down from $146.8 million in the prior quarter.
  • Over five years, Receivables - Net peaked at $146.8 million in Q3 2025 and troughed at $67.9 million in Q2 2021.
  • A 5-year average of $108.8 million and a median of $109.8 million in 2023 define the central range for Receivables - Net.
  • Biggest five-year swings in Receivables - Net: fell 6.12% in 2022 and later soared 54.33% in 2023.
  • Year by year, Receivables - Net stood at $78.8 million in 2021, then rose by 12.69% to $88.8 million in 2022, then increased by 29.43% to $114.9 million in 2023, then increased by 18.57% to $136.3 million in 2024, then grew by 5.33% to $143.6 million in 2025.
  • Business Quant data shows Receivables - Net for AMPH at $143.6 million in Q4 2025, $146.8 million in Q3 2025, and $133.0 million in Q2 2025.